Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles

Details for Australian Patent Application No. 2008260070 (hide)

Owner Wyeth LLC

Inventors Hewes, Becker

Agent Spruson & Ferguson

Pub. Number AU-B-2008260070

PCT Pub. Number WO2008/150957

Priority 60/932,650 01.06.07 US

Filing date 30 May 2008

Wipo publication date 11 December 2008

Acceptance publication date 18 August 2011

International Classifications

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/150957 Priority application(s): WO2008/150957

18 August 2011 Application Accepted

  Published as AU-B-2008260070

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008260075-Method to predict or diagnose a gastrointestinal disorder or disease

2008260062-Humanized antibodies to Abeta(20-42) globulomer and uses thereof